Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: A US-based study
Christopher R. Frei, T. C. Jaso, E. M. Mortensen, M. I. Restrepo, M. K. Raut, C. U. Oramasionwu, A. D. Ruiz, B. R. Makos, J. L. Ruiz, R. T. Attridge, S. H. Mody, A. Fisher, J. R. Schein
Dive into the research topics of 'Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: A US-based study'. Together they form a unique fingerprint.